EGFR806-specific CAR T Cell Therapy

EGFR806-targeted chimeric antigen receptor T cell · Seattle Children's Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EGFR806-specific CAR T Cell Therapy, covering 2025-12-17 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors [Phase 1]

See pricing